304 related articles for article (PubMed ID: 31929360)
1. Semaphorin 3A-hypoxia inducible factor 1 subunit alpha co-overexpression enhances the osteogenic differentiation of induced pluripotent stem cells-derived mesenchymal stem cells in vitro.
Li JY; Wang TT; Li C; Wang ZF; Li S; Ma L; Zheng LL
Chin Med J (Engl); 2020 Feb; 133(3):301-309. PubMed ID: 31929360
[TBL] [Abstract][Full Text] [Related]
2. Sema3A and HIF1α co-overexpressed iPSC-MSCs/HA scaffold facilitates the repair of calvarial defect in a mouse model.
Li J; Wang T; Li C; Wang Z; Wang P; Zheng L
J Cell Physiol; 2020 Oct; 235(10):6754-6766. PubMed ID: 32012286
[TBL] [Abstract][Full Text] [Related]
3. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH
Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway.
Sun Z; Yan K; Liu S; Yu X; Xu J; Liu J; Li S
J Mol Histol; 2021 Dec; 52(6):1245-1255. PubMed ID: 33566267
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering.
Liu J; Chen W; Zhao Z; Xu HH
Biomaterials; 2013 Oct; 34(32):7862-72. PubMed ID: 23891395
[TBL] [Abstract][Full Text] [Related]
7. Effect of NELL1 gene overexpression in iPSC-MSCs seeded on calcium phosphate cement.
Liu J; Chen W; Zhao Z; Xu HHK
Acta Biomater; 2014 Dec; 10(12):5128-5138. PubMed ID: 25220281
[TBL] [Abstract][Full Text] [Related]
8. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells.
Wang P; Ma T; Guo D; Hu K; Shu Y; Xu HHK; Schneider A
J Tissue Eng Regen Med; 2018 Feb; 12(2):437-446. PubMed ID: 28494141
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic differentiation and bone regeneration of iPSC-MSCs supported by a biomimetic nanofibrous scaffold.
Xie J; Peng C; Zhao Q; Wang X; Yuan H; Yang L; Li K; Lou X; Zhang Y
Acta Biomater; 2016 Jan; 29():365-379. PubMed ID: 26441129
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
11. Benefits of biphasic calcium phosphate hybrid scaffold-driven osteogenic differentiation of mesenchymal stem cells through upregulated leptin receptor expression.
Niu CC; Lin SS; Chen WJ; Liu SJ; Chen LH; Yang CY; Wang CJ; Yuan LJ; Chen PH; Cheng HY
J Orthop Surg Res; 2015 Jul; 10():111. PubMed ID: 26179165
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.
Lotz EM; Berger MB; Boyan BD; Schwartz Z
Bone; 2020 May; 134():115260. PubMed ID: 32028017
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
[TBL] [Abstract][Full Text] [Related]
14. miR-101-loaded exosomes secreted by bone marrow mesenchymal stem cells requires the FBXW7/HIF1α/FOXP3 axis, facilitating osteogenic differentiation.
Li Y; Wang J; Ma Y; Du W; Feng K; Wang S
J Cell Physiol; 2021 Jun; 236(6):4258-4272. PubMed ID: 33438204
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of mouse-induced pluripotent stem cells and mesenchymal stem cells during osteogenic differentiation in vitro.
Egusa H; Kayashima H; Miura J; Uraguchi S; Wang F; Okawa H; Sasaki J; Saeki M; Matsumoto T; Yatani H
Stem Cells Dev; 2014 Sep; 23(18):2156-69. PubMed ID: 24625139
[TBL] [Abstract][Full Text] [Related]
16. Sema3A Modified PDLSCs Exhibited Enhanced Osteogenic Capabilities and Stimulated Differentiation of Pre-Osteoblasts.
Wang W; Chen B; Yang J; Li Y; Ding H; Liu H; Yuan C
Cell Biochem Biophys; 2023 Sep; 81(3):543-552. PubMed ID: 37421591
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of mesenchymal stem cells osteogenic differentiation on low-temperature biomineralized nanocrystalline carbonated hydroxyapatite and sintered hydroxyapatite.
Hesaraki S; Nazarian H; Pourbaghi-Masouleh M; Borhan S
J Biomed Mater Res B Appl Biomater; 2014 Jan; 102(1):108-18. PubMed ID: 23853054
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use.
Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS
Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996
[TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.
Yang H; Feng R; Fu Q; Xu S; Hao X; Qiu Y; Feng T; Zeng Z; Chen M; Zhang S
Cell Death Dis; 2019 Sep; 10(10):718. PubMed ID: 31558705
[TBL] [Abstract][Full Text] [Related]
20. Stromal-cell-derived extracellular matrix promotes the proliferation and retains the osteogenic differentiation capacity of mesenchymal stem cells on three-dimensional scaffolds.
Antebi B; Zhang Z; Wang Y; Lu Z; Chen XD; Ling J
Tissue Eng Part C Methods; 2015 Feb; 21(2):171-81. PubMed ID: 24965227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
